PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1627816
PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1627816
The Indonesia Syringe Market is expected to grow at a rate of 75.67% CAGR, reaching a market size of US$290.446 million in 2030 from US$220.495 million in 2025.
A syringe is a glass or plastic tube containing a needle on one side. It is used to deliver the drug to the veins of the body or for taking small samples of blood for medical tests and procedures. A syringe is among the most important types of medical devices, which helps medical professionals. It has multiple benefits, like elimination of dose errors, and offers easy application and administration of medicines.
Indonesia is benefiting from greater purchasing power and improved exposure to healthcare facilities as the country's economic situation improves. The government has substantially enhanced expenditures on health care and programs supported by medicine for Indonesia's poor households. The lifestyle and dietary habits of Indonesians are changing as a result of the country's improving economic situation. This aggravates lifestyle-related health conditions like high blood pressure and hypertension. As a result, the demand for medicines and the medical equipment needed to administer them, such as syringes, has surged in Indonesia in recent years, supporting the country's syringe industry.
Hence, the growing healthcare sector in Indonesia is witnessing rapid industry development through continued efforts from governments and private organizations, leading to the market expansion of Indonesian syringes. The International Trade Administration in its report has projected the nation's growth at about US$3,355 million, with about US$2,331 million of local healthcare production in 2021. The local production of healthcare increased to US$2,5641 million in 2022, which further rose to about US$2,808 million in 2023. This data by the International Trade Administration shows the growing healthcare sector in Indonesia which is leading the market growth of its associated industries including the syringe market.
Indonesia's syringe market drivers
In Indonesia, there are many cases of unusual diseases and fatal ailments. According to data from the World Health Organization (WHO), there were around 11.66 million active cases affected by kidney diseases while there were more than 10 million active diabetes patients in Indonesia in 2021. The data also stated that there were 260K patients suffering from cardiac ailments and around 400K people were suffering from different types of cancers and tuberculosis respectively in 2021. As such, the rising prevalence of several diseases and the increasing number of patients suffering from such ailments has resulted in increased demand for medical equipment for treatment, including syringes, defibrillators, and surgical tables. As such, the growing patient population in the country has favourably impacted the Indonesian syringe market.
Reasons for buying this report:-
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence